The minor house dust mite allergen Der p 13 is a fatty acid binding protein and an activator of a TLR2-mediated innate immune response by Satitsuksanoa, Pattraporn et al.
 
 
 
 
Satitsuksanoa, P. et al. (2016) The minor house dust mite allergen Der p 13 
is a fatty acid binding protein and an activator of a TLR2-mediated innate 
immune response. Allergy, 71(10), pp. 1425-1434. (doi:10.1111/all.12899) 
 
This is the author’s final accepted version. 
 
There may be differences between this version and the published version. 
You are advised to consult the publisher’s version if you wish to cite from 
it. 
 
 
 
 
http://eprints.gla.ac.uk/118175/ 
     
 
 
 
 
 
 
Deposited on: 3 May 2016 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten – Research publications by members of the University of Glasgow 
http://eprints.gla.ac.uk 
The minor house dust mite allergen Der p 13 is a fatty acid binding protein and an 1 
activator of a TLR2-mediated innate immune response 2 
Pattraporn Satitsuksanoa1, Malcolm Kennedy2, Dimitri Gilis3, Maxime Le Mignon4, 3 
Narissara Suratannon5, Jongkonnee Wongpiyabovorn6, Pantipa Chatchatee5, Mukda 4 
Vangveravong7, Ticha Rerkpattanapipat8 , Atik Sangasapaviliya9, Surapon Piboonpocanun10, 5 
Emmanuel Nony4, Kiat Ruxrungtham1, Alain Jacquet1 and the Mite Allergy Research Cohort 6 
(MARC) study team 7 
1. Division of Allergy and clinical Immunology, Department of Medicine; and Chula 8 
Vaccine Research Center (Chula VRC), Faculty of Medicine, Chulalongkorn 9 
University, Bangkok 10330, Thailand. 10 
2. Institute of Biodiversity, Animal Health and Comparative Medicine, College of 11 
Medical, Veterinary and Life Sciences, Graham Kerr Building, University of 12 
Glasgow, Glasgow G12 8QQ, Scotland, UK. 13 
3. BIO-Bioinfo Department, Université Libre de Bruxelles, Avenue F. Roosevelt 50 CP 14 
165/61 1050 Brussels, Belgium  15 
4. Stallergenes Greer, Antony 92160, France. 16 
5. Division of Allergy and Immunology, Department of Pediatrics, Faculty of Medicine, 17 
Chulalongkorn University, Bangkok 10330, Thailand. 18 
6. Center of Excellence in Immunology and Immune Mediated Diseases, Division of 19 
Immunology, Department of Microbiology, Faculty of Medicine, Chulalongkorn 20 
University, Bangkok 10330, Thailand. 21 
7. Allergy, Immunology and Rheumatology Unit, Queen Sirikit National Institute of 22 
Child Health, Department of Medical Services, Ministry of Public Health, Bangkok, 23 
Thailand 10400 24 
8. Division of Allergy, Immunology and Rheumatology, Department of Medicine, 25 
Faculty of Medicine, Ramathibodi hospital, Mahidol University, Bangkok 10400, 26 
Thailand. 27 
9. Division of Allergy and Clinical Immunology, Department of Medicine, 28 
Phramongkutklao Hospital, Bangkok 10400, Thailand 29 
10. Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom 73170, 30 
Thailand. 31 
Running title: Allergenic determinants of house dust mite allergen Der p 13 32 
 33 
Corresponding author: 34 
Assoc. Prof. Dr. Alain Jacquet 35 
Department of Medicine, Faculty of Medicine, 36 
Chulalongkorn University, 37 
1873 Rama IV Road, Pathumwan, 38 
Bangkok 10330, Thailand. 39 
Tel: (+66) 02 2563659 40 
Fax: (+66) 02 6523100 41 
E-mail: alain.j@chula.ac.th  42 
 43 
Keywords: Allergen, Der p 13, house dust mite, IgE reactivity, innate immunity, lipid 44 
binding protein, TLR2. 45 
Intro/Mat Met/Results/Discussion: 3385 46 
47 
Abstract (N= 243) 48 
 49 
Background: The house dust mite (HDM) allergen Der p 
Introduction 70 
Sensitization to house dust mites (HDM) can trigger strong allergen-induced inflammation of 71 
the skin and airway mucosa resulting in atopic dermatitis as well as allergic rhinitis and 72 
asthma (1). In the most studied HDM species, Dermatophagoides pteronyssinus (Der p) and 73 
Dermatophagoides farinae (Der f), protein allergens have been classified as being major, 74 
intermediate, or minor allergens according to their IgE binding frequencies in HDM allergic 75 
patient cohorts (2). On the basis of IgE binding frequency as a hypothetical criterion for 76 
allergenicity, allergens from groups 1 and 2 have been proposed to be significant inducers of 77 
IgE responses, unlike those in groups 4, 5, 7, 21 and 23, which are targets of low to 78 
intermediate IgE binding frequencies (3). However, a growing literature points towards a 79 
critical role for innate immune pathways in the initiation of HDM allergic responses. It has 80 
consequently been proposed that a new allergen classification is warranted, based on their 81 
propensities in activating innate responses (4). For instance, the HDM serine protease 82 
allergens Der p/f 3, Der p/f 6 and Der p/f 9, despite having low IgE binding frequencies, 83 
activate innate immune cells to initiate or prolong the HDM-induced allergy pathogenesis, 84 
possibly through the protease-activated receptor 2 (PAR-2) (5).  85 
Lipid binding capacity is another potential allergenic determinant commonly observed in 86 
proteins triggering allergic responses, including Bet v 1-like molecules, non-specific lipid 87 
transfer proteins (nLTP), and lipid-binding lipocalins (6). Lipids may also influence the early 88 
stages of the allergic response through TLR4- and TLR2-dependent mechanisms. Several 89 
HDM allergens, Der p/f 2, Der p/f 5, Der p/f 7, Der p/f 21 have been considered to be lipid-90 
binding proteins that may have allergenic potential, in cellular assays, or in-vivo experiments 91 
using TLR4 and MD2-deficient mice (7-11). Group 13 mite allergens display clear sequence 92 
similarities with cytoplasmic fatty acid binding proteins (FABPs) and consequently could 93 
also be of importance in innate immune signaling through associations with mite or microbial 94 
lipids (2). With the exception of the B. tropicalis allergen Blo t 13, which has been shown to 95 
bind fatty acids (12), the capacity of other group 13 mite allergens to stimulate innate 96 
immunity through their lipid cargo remains to be assessed. The goal of the present study was 97 
to investigate a recombinant form of Der p 13 in terms of IgE reactivity, lipid binding 98 
propensity, and airway epithelial cell activation. 99 
100 
101 
Materials and methods 102 
All the methods used are described in the online supporting information of this article. 103 
104 
Results 105 
Physico-chemical analysis of rDer p 13 and detection of natural Der p 13 (nDer p 13) in 106 
mite bodies. 107 
SDS-PAGE profiles of rDer p 13 were shown to be similar under both reducing 108 
(Fig.1.A) and non-reducing conditions (data not shown) and confirmed that the product 109 
was homogeneous and displayed the expected relative mobility (Mr) around 15kDa. 110 
Dynamic light scattering (DLS) experiment confirmed that purified rDer p 13 is 111 
monomeric, with no or only trace amounts of polymers or aggregates (data not shown). 112 
NanoLC-MS analysis of the intact protein confirmed the expected mass at 15276.9 Da, 113 
corresponding to the mature Der p 13 sequence (amino acids 2-131) with four extra N-114 
terminal amino acids derived from the expression vector (Glu-Ala-Val-Ala) (Fig. 1.B)  115 
Far UV circular dichroism (CD) analysis of recombinant (r)Der p 13 yielded a spectrum 116 
typical of a folded protein with ² -sheet structure predominating (Supplementary Fig. 1.C). 117 
Estimates of the secondary structure content using CDpro software indicated 37.5% ² -sheet, 118 
12.5% ±-helix, 19% turns and 31% unstructured. We also confirmed by immunoblotting that 119 
mouse polyclonal antibodies to rDer p 13 react with the natural molecule present in 120 
commercially-available mite bodies but not in mite faeces (Fig. 1.D), which is consistent with 121 
Der p 13 belonging to the FABP family of proteins that are usually confined to cell cytoplasm 122 
and not secreted (13). 123 
 124 
IgE reactivity to rDer p 13 and basophil degranulation assays 125 
Using 224 sera from HDM-allergic patients (Dpt ImmunoCap Class 3 or higher values) 126 
suffering from allergic rhinitis or asthma, the IgE reactivity to rDer p 13 was determined by 127 
sandwich ELISA and compared with the IgE binding capacity of rDer p 2. Fifteen out of 224 128 
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patients displayed specific IgE to rDer p 13 (7%), whereas 75% (169/224) of the same cohort 138 
exhibited specific IgE to rDer p 2. Our data therefore confirm that Der p 13 is classifiable as a 139 
minor allergen in that it is a target of IgE antibody in a low proportion of the HDM-allergic 140 
population. There remains, however, the possibility that a complex of Der p 13 and its 141 
resident lipid from HDM could be involved in allergic sensitization to itself and other HDM 142 
allergens. We therefore investigated compared the allergen activity of rDer p 2 and rDer p 143 
13 activity in a rat basophil degranulation assay using the RBL SX-38 cells (rat basophil 144 
leukemia cells expressing the human FcµRI receptor) preloaded with sera from patients 145 
sensitized to nDer p 2 or nDer p 13 (14). Regardless of the sera used, similar levels of cell 146 
activation  were observed (P>0.5) by addition of polyclonal anti-human IgE (0.1 µg/ml), 147 
causing around 50% of the total hexosaminidase release. Cell incubation with rDer p 13 148 
triggered allergen concentration-dependent basophil degranulation following a typical bell 149 
shape curve, with a maximum reached with 0.01 µg/mL (Fig. 2). Using the same allergen 150 
concentration, rDer p 2 triggered significantly higher levels of degranulation (P<0.05), 151 
indicating that Der p 2 exhibits more allergen activity than Der p 13.  152 
153 
Lipid binding by Der p 13 154 
Lipid-binding assays were performed using different fluorophore-conjugated or intrinsically 155 
fluorescent fatty acids (bodipy-C16, 11-([5-dimethylaminonaphthalene-1-sulfonylamino]) 156 
undecanoic acid (DAUDA), dansyl-DL-±-aminocaprylic acid (DACA), cis-parinaric acid 157 
(cPnA) and dehydroergosterol (DHE)) as well as probes for apolar surfaces and binding 158 
pockets (1-anilinonapthalene-8-sulfonate (ANS), bis-ANS). As shown in Fig. 3A, the 159 
fluorescence emission of the natural, non-conjugated fluorescent fatty acid cPnA was 160 
significantly enhanced when mixed with rDer p 13, indicating the entry of the fatty acid into 161 
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a non-polar site. No binding by the fluorophore-conjugated fatty acids bodipy-C16, DAUDA 169 
or DACA was observed, although control experiments with a lipid-binding protein as positive 170 
controls showed binding as expected (bovine serum albumin; data not shown). Interactions 171 
between Der p 13 and ANS were observed, but only minimally with bis-ANS. Addition of 172 
oleic acid to pre-formed Der p 13:cPnA complexes failed to show any significant competitive 173 
displacement, whereas control experiments with cPnA and a well-characterized fatty acid 174 
binding protein, ² -lactoglobulin, showed efficient dose-dependent competitive displacement 175 
(Fig.3.B. data not shown). These results could be interpreted as meaning that lipid ligands 176 
bearing bulky fluorophore adducts (DAUDA, DACA and bodipy-C16) or molecules of 177 
relatively large diameters (bis-ANS) are excluded from Der p 13’s binding site. The 178 
enhancement of cPnA’s fluorescence emission when mixed with Der p 13 is indicative of 179 
entry to a binding pocket removed from polar solvent water. The relatively poor displacement 180 
of cPnA by oleic acid from that binding site is indicative of Der p 13’s affinity for fatty acids, 181 
but selectively so. Fluorescence titration experiments showed that binding of cPNA to rDer p 182 
13 was saturable with a dissociation constant Kd of 0.4 µM, which is typical of a lipid 183 
transporter protein (12), and with an apparent stoichiometry consistent with a 1:1 binding 184 
(Fig.3.C B).185 
Modeling of the Der p 13 tertiary structure and its complex with cPNA 186 
The analysis of the empirical structure of Der f 13 has previously shown that it, in common 187 
with other family 13 members, shares close structural similarities to cytoplasmic FABPs (15). 188 
FABPs adopt an apo form in the absence of ligand, lipid binding then inducing detectable 189 
conformational changes. In human muscle FABP, the main difference between apo and holo 190 
forms is the orientation of residue Phe57 (16), and other slight changes in the portal residues 191 
of the binding cavity involving Val25, Thr29, Lys58, Ala75 and Asp76. Interestingly, all 192 
these residues are conserved in Der p 13, with the exception of position 29, where there is a 193 
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Val. MODELLER 9.14 software (salilab.org) was used to predict the 3D structure of an apo 201 
form of Der p 13 based on the NMR structure of Der f 13 (PDB code 2A0A) (15) and of a 202 
holo form using as template the structure of myelin P2 protein in complex with ligand (PDB 203 
code 1YIV) (17) (Fig. 4.A and 4.B, respectively). Comparison of Figs. 4.A and 4.B shows an 204 
opening of the region around residue Phe57 in the model of the holo form. A central cavity 205 
that could accommodate an apolar ligand such as a fatty acid is present in both models, with 206 
an estimated volume of 590 Å3 by CASTp (18). To investigate whether the highly conjugated 207 
fatty acid cPNA could theroretically interact with the hydrophobic pocket of Der p 13, the 208 
protein-lipid docking with both models was simulated using the AutodockVina software. The 209 
results show that cPNA cannot enter the cavity of the Der p 13 apo model in which the portal 210 
is obscured by Phe57, but could be ligated to the exterior surface of a small cavity which 211 
represents the portal of entry to the hydrophobic pocket. The computed Gibbs free energy of 212 
binding of cPNA at the protein surface is -5.2 kcal/mol, which corresponds to a binding 213 
affinity (Kdissociation) of about 250 µM, which is weak for a protein:ligand interaction. This 214 
inaccessibility of the fatty acid to the internal cavity is a consequence of the conformation 215 
change of the Phe57 residue in the static template apoFABP (16), which is probably not 216 
realistic. Assuming a similar mechanism in Der p 13, we docked cPNA in the model of the 217 
holo form, in which Phe57 is angled away from the presumed portal, obtaining a complex in 218 
which cPNA docks readily into the predicted hydrophobic pocket (Fig. 4.C). The computed 219 
Gibbs free energy in this case was -6.7 kcal/mol, which brings the theoretical Kdissociation to 220 
about 12 µM. This value is closer to, but still weaker, than the value obtained from the 221 
empirical protein:cPnA titration analysis (see above). This suggests that cPNA binds 222 
preferentially in the cavity rather than at the surface of Der p 13, as expected in other FABPs 223 
(19, 20), and is consistent with the spectrofluorometric finding that cPnA’s fluorescence 224 
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emission is enhanced to a degree expected for its removal from solvent water into an apolar 225 
protein environment. 226 
 227 
Der p 13 activates airway epithelial cells through TLR2 228 
To investigate whether Der p 13 could activate the airway epithelium through 229 
proinflammatory cytokine induction, human bronchial epithelial BEAS-2B cells were 230 
incubated with different rDer p 13 concentrations  under serum-free conditions, followed 231 
by measurement of IL-8 and GM-CSF levels in culture supernatants. As a positive control, 232 
cells were stimulated with the Pam3Cys4 TLR2 ligand. When compared with the control 233 
medium, rDer p 13 elicited the production of IL-8 and GM-CSF in a concentration-dependent 234 
manner (Fig. 5.A and B). Supernatants from methanol-induced wild-type KM71 cells that 235 
had been treated as for the rDer p 13 purification protocol did not stimulate the release of 236 
these cytokines, thereby assuring that the allergen-induced IL-8/GM-CSF expression was not 237 
due to trace contaminants in the protein preparation.  238 
Given the propensity of Der p 13 to transport specific lipids, we hypothesized that the Der p 239 
13-induced cytokine release might be mediated by TLR2, this receptor being activated by 240 
microbial lipoprotein/lipid ligands (21). As shown in Fig. 5C, preincubation of cells with 241 
blocking anti-human TLR2 mAb drastically reduced the Der p 13-induced IL-8 secretion 242 
from BEAS-2B cells. This TLR2 dependence was not replicated by the isotype control 243 
antibody. To confirm the specificity of such TLR2 activation, similar assays were 244 
performed with purified recombinant allergens rProDer p 1 (REF) and rDer p 23 245 
(REF), two proteins produced in  that have known lipid binding activities. 246 
Under the same experimental conditions, rProDer p 1 was unable to stimulate the 247 
production of IL-8 (data not shown) whereas rDer p 23-induced cytokine production 248 
was TLR2-independent (Fig.5.C). 249 
production  
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Given that TLR2 engages with the MyD88 adaptor protein (22), the involvement of MyD88 252 
in the rDer p 13-induced cell activation was also investigated using a dominant negative 253 
MyD88 expression plasmid (DN-MyD88) to down-regulate MyD88 activity. Treatment of 254 
BEAS-2B cells transfected with DN-MyD88 drastically reduced IL-8 secretion (Fig.5.D), but 255 
no effect was observed with the control plasmid. 256 
Since NF-º B and MAP kinases are known to contribute to cytokine production in stimulated 257 
airway epithelium (23), we next examined the role of ERK, p38 and JNK and NF-kB 258 
activation on the production of IL-8 from BEAS-2B cells in response to rDer p 13, by using 259 
specific pharmacological inhibitors. The blockade of MAPK pathways through cell 260 
pretreatments with U0126 (MEK1/2 inhibitor), SB203580 (p38 MAPK inhibitor) or 261 
SP600125 (JNK inhibitor), respectively, reduced the IL-8 up-regulation caused by rDer p 13 262 
(Fig. 5E). Similar reduction of IL-8 release was observed with IkB-± phosphorylation BAY-263 
11-7082 and proteasome MG132 inhibitors (Fig.5.E), suggesting that the three MAPK 264 
signaling cascades and NF- B were essential for the IL-8 production by rDer p 13-stimulated 265 
BEAS-2B cells. The observed inhibition of rDer p 13-induced IL-8 expression did not 266 
result from cytotoxicity of these inhibitors because the total number of cells and cell 267 
viability at the end of culture period for each experiment were similar among all culture 268 
conditions (data not shown). 269 
Finally, to investigate the potential involvement in rDer p 13-induced cell activation of lipid 270 
present in the allergen’s apolar pocket, we measured the IL-8 production when BEAS2-B 271 
cells were treated with rDer p 13 that had been extensively digested with trypsin. Treatment 272 
with trypsin at 37°C for 1h (rDer p 13:trypsin ratio 20:1) degraded the recombinant allergen 273 
(Fig.5.F). Strikingly, such rDer p 13 hydrolyzate was shown to retain its capacity to trigger 274 
the IL-8 release in BEAS-2B cells (Fig.5.G). The cytokine production was not due to the 275 
presence of trypsin because digested Der p 13 was treated prior to cell exposure with 276 
as  
immobilized benzamidine, a matrix that traps and depletes this protease. The efficacy of 278 
trypsin removal was confirmed by the absence of cell activation with trypsin preincubated 279 
with the benzamidine matrix. These results suggest that a the lipidic ligand of yeast origin 280 
and transported by in Der p 13 may be influential in the allergen’s effect on the airway 281 
epithelial cells.  282 
283 
from  
Discussion 285 
 286 
We previously demonstrated that the HDM allergens Der p 2 and Der p 23 triggered allergic 287 
sensitization in a large percentage of Thai HDM-allergic patients with frequencies similar to 288 
those measured in western countries (24). To determine whether the level of sensitization to 289 
minor HDM allergens were similar among Thai and western populations, the present study 290 
focused on Der p 13, a member of group 13 mite allergens that has been poorly investigated 291 
to date. To our knowledge, only one publication partially described the production of 292 
rDer p 13 in bacteria and, moreover, the characterization was restricted to its IgE 293 
reactivity (REF). Studies that surveyed IgE reactivities to Recombinant group 13 mite 294 
allergens, including rBlo t 13, rTyr p 13, rAca s 13, rLep d 13 and rDer p 13 produced in E. 295 
coli, demonstrated that they typically were shown to display a low prevalence of 296 
sensitization in the HDM allergic population (25-29). IgE binding frequencies against Der p 297 
13, Blo t 13, Tyr p 13, Lep d 13 and Aca s 13 reached 6%, 7-11%, 6%, 13% and 23%, 298 
respectively. Because these data were generated using recombinant allergens produced in E. 299 
coli, some of which were expressed as inclusion bodies, there is a possibility of 300 
underrepresentation because of inappropriate folding. Assessments of recombinant allergen 301 
folding are rarely performed, with the exception of the characterization of the Blo t 13 302 
secondary structure (12) and the elucidation of the Der f 13 structure by NMR (15). 303 
We produced Der p 13 in P. pastoris as a secreted protein, and CD analysis indicated that it 304 
exhibits secondary structure content  typical of members of the FABP family. Using this 305 
recombinant allergen we found that, while the IgE binding frequency of rDer p 2 reached 306 
75% (169/224 patients), reactivity to rDer p 13 was only 7% (15/224 patients) in this thai 307 
HDM allergic population but reached around 20% in HDM allergic patients living in 308 
other areas (REF). Such low frequency of reactivity to Der p 13, as with other members of 309 
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group 13 mite allergens (25-29), may be due to the fact that cytoplasmic FABP allergens are 317 
restricted to mite bodies and not present in the faeces (3). Whereas fragmented mite body 318 
parts together with fecal pellets represent the main allergenic source, the deep penetration of 319 
particles with allergen cargo into the lung must be size-dependent (30). Consequently, the 320 
HDM allergens transported within mite fecal pellets (10 µm average diameter) should trigger 321 
airway inflammation more readily than mite body parts. To support this hypothesis, it has 322 
recently been demonstrated that HDM allergens detectable only in mite bodies display weak 323 
IgE reactivity in sensitized population with respiratory symptoms, but represent major 324 
allergens in patients suffering from atopic dermatitis (31). The HDM allergics in our cohort 325 
suffered only from allergic rhinitis or asthma, so it would be interesting to determine whether 326 
HDM allergics with atopic dermatitis have similar or higher rates of IgE to Der p 13.  327 
It is widely accepted that HDM allergies may be initiated through activation of innate 328 
immunity (4), such that any mite component capable of stimulating innate immune signaling 329 
could be influential. Pertinent to the role of specific lipids in immune activation, we 330 
demonstrated, using environment-sensitive fluorescent lipid probes, that rDer p 13 binds fatty 331 
acids and that the protein’s binding to hydrophobic ligands is selective. Indeed, although 332 
Der p 13 and Blo t 13 share 80% amino acid sequence identity and display similar Kd 333 
values for cPNA (0.4 10-6 M versus 1.31 10-6 M, respectively), displacement of cPNA 334 
with oleic acid was ineffective for Der p 13, unlike with Blo t 13 (ref.). This may 335 
therefore mean that, despite their sequence and structural similarities, the precise 336 
binding propensities of the two proteins differ. 337 
Computer-based docking experiments performed with two different models of Der p 13 (one 338 
based on the apo form of Der f 13, (15) the other based on the holo form of myelin P2 339 
protein, (17)) with the lipid ligand cPnA known to bind to the protein, predicted that the 340 
accessibility of the hydrophobic pocket could be controlled by the side chain orientation of 341 
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Phe57. This residue is located immediately beside the portal of entry to the binding pocket of 353 
some FABPs (16). A similarly-positioned side chain is found in several FABPs (32), where it 354 
is speculated to regulate the entry of ligand to the proteins’ binding pockets (20).  The 355 
identification of the lipid ligand(s) naturally present in the Der p 13 hydrophobic pocket 356 
remains  to be determined. Der p 13, like all FABPs other than those of nematodes (33), lacks 357 
a leader sequence, and is therefore probably confined to the cytosol of mite cells. The lipids it 358 
may present are therefore likely to be cytoplasmic lipids, though we cannot exclude the 359 
possibility that Der p 13 transports lipid ligands from endosymbiotic bacteria or microbes in 360 
house dust.  361 
Based on the finding that Der p 13 binds fatty acids, we hypothesized that this allergen could 362 
activate TLR2 signaling in airway epithelium. This pathogen-associated molecular pattern 363 
receptor forms a heterodimer with either TLR1 or TLR6 and interacts with lipids/fatty acids 364 
or lipoprotein (34). The activation of TLR4 in combination with MD2 and CD14 (another 365 
receptor recognizing microbial lipidic ligands) by Der p 13 was not evaluated because the 366 
BEAS-2B airway epithelial cells were found to be hyporesponsive to the LPS needed as a 367 
positive control (data not shown). Indeed, such cells were shown to express MD2 poorly 368 
whereas intracellular localization of TLR4 is nevertheless apparent (35).  369 
To determine whether rDer p 13 enhances innate responses through TLR2, proinflammatory 370 
cytokine production was measured from stimulated BEAS 2B. We focused on both IL-8 and 371 
GM-CSF secretion because these cytokines are important chemoattractants and activators for 372 
immune cells such as neutrophils, basophils, eosinophils and dendritic cells (36). Our results 373 
showed that rDer p 13 stimulated the production of IL-8 and GM-CSF by airway epithelial 374 
cells in a time- and concentration-dependent manner. Through a combination of blocking 375 
antibodies, specific inhibitors, and depletion of MyD88, we found that Der p 13 triggers 376 
airway epithelial cell activation through TLR2-MyD88-NF- B and MAPK-dependent 377 
capable to r 
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mechanisms. Strikingly, this cell activation was shown to be independent of the persistence 382 
of intact Der p 13, thereby implicating the protein’s lipid cargo. This result supported the 383 
hypothesis that Der p 13 facilitates the transfer of immunomodulatory fatty acid/lipid to 384 
TLR2 or to a TLR2 co-receptor such as CD14 or CD36 to trigger innate immune signaling. 385 
 386 
To our knowledge, this is the first study to reveal the allergenic propensity of a group 13 mite 387 
allergen as well as its potential mechanism of action. Together with group 2 allergens and 388 
Der p 21 (37, 11), Der p 13 is the third TLR2 stimulator to be identified in HDM. Notably, 389 
the presence of hydrophobic cavities in the Der p 5 dimer and Der p 7 structures that 390 
potentially bind apolar ligands suggests that HDM allergens transporting lipid cargo could act 391 
either synergistically or in a redundant fashion to stimulate TLR2 signaling (9, 10). 392 
Immunomodulatory activities exhibited by Der p 5 and Der p 7, however, await direct 393 
experimentation. Although it was demonstrated initially that TLR2 ligands reduced Th2-394 
biased allergic responses (38), recent studies indicated that TLR2 signaling could be critical 395 
for the development of HDM allergic rhinitis and asthma (39-42). In that context, Der p 13 396 
could represent an important factor in the initiation of the HDM allergic response because 397 
TLR2 engagement led to the activation of the epithelial NF- B, which comprises an 398 
orchestrator of the HDM-induced airway inflammation, hyperresponsiveness, and fibrotic 399 
remodeling (43). 400 
 401 
In conclusion, Der p 13, through its ability to bind lipid and trigger TLR2-dependent innate 402 
immune signaling, must be considered as a potential contributor to the induction of the HDM 403 
allergic response. Although Der p 13 appears strictly to be confined within fragmented 404 
mite bodies, we speculate that TLR2 activation could occur  following deposition 405 
of mite fragments onto the lung surface with consequent allergen release. It must be 406 
for the  
ing of lipid 
The i 
capacities  
of  
experimental confirmation 
was  
localized  
into  
such  
 
bodies  
and  
 by the unknown action of a  
dissolving media in the lung the epithelial  
lining fluid.  
pointed out that Der p 2 is also mainly present in mite bodies yet is a major allergen 423 
able to activate TLR2 and TLR4 (REF).  Because the lipid environment in the mite, house 424 
dust or the P. pastoris yeast used to produce the allergen may differ considerably, it is 425 
important ultimately to identify the natural Der p 13 ligand(s) and to characterize its effects 426 
on immune cells. Also, the lipid transfer mechanism involved in the Der p 13-mediated 427 
enhancement of TLR2 signaling remains unclear, although FABPs of the sub-family to which 428 
Der p 13 belongs are known to interact directly with membranes in the transfer of lipid cargo 429 
(44). Nevertheless, our results demonstrate that the HDM allergen hierarchy, based 430 
essentially on IgE reactivities, needs further refinement in order to take into account the 431 
capacity of allergens to stimulate innate immunity. Consequently, minor HDM allergens such 432 
as Der p 13 require further consideration in order to elucidate their abilities to activate airway 433 
epithelial cells as well as keratinocytes. 434 
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468 
Figure legends 469 
Figure 1. Detection of nDer p 13 in HDM allergen extracts from  470 
Immunoblot detection of nDer p 13 using anti-rDer p 13 mouse polyclonal antibodies. Lane 471 
1: D. pteronyssinus fecal pellet extract, Lane 2: D. pteronyssinus mite bodies extract 472 
(Stallergenes Greer), Lane 3: purified rDer p 13.  473 
 474 
Figure 2. RBL-SX38 cell degranulation by rDer p 13 and rDer p 2.  475 
Cells were primed for 16 h with sera from three HDM allergic patients, containing rDer p 13- 476 
(Panel A) or rDer p 2-specific IgE (Panel B).and subsequently stimulated with serial dilutions 477 
of purified rDer p 13 or rDer p 2 for 30 min. Degranulation was measured through ² -478 
hexasominidases activity. Percentage of degranulation was presented as subtraction of 479 
spontaneous released over total lysis with Triton X-100. 480 
 481 
Figure 3. Hydrophobic ligand binding activity of rDer p 13.  482 
Panel A: Fluorescence emission spectra of cis-parinaric acid (cPnA, Exmax = 319nm) bound to 483 
purified rDer p 13. The competitive binding of oleic acid used at different concentrations 484 
(7.9µM, 79µM, 790µM) is also shown. Curve A: PBS, curve B: cPnA alone, curve C: cPNA 485 
+ rDer p 13, curve D: cPNA:rDer p 13 complex + 7.9 µM oleic acid, curve E: cPNA:rDer p 486 
13 complex + 79 µM oleic acid, curve F: cPNA:rDer p 13 complex + 790 µM oleic acid. RFI 487 
= relative fluorescence intensity. One representative experiment out of 3 is shown.  488 
Panel B. Titration curve of cPnA binding to rDer p 13.#Change in relative fluorescence 489 
intensity of cPNA following addition of increasing rDer p 13 concentrations. The solid line 490 
represents the theoretical binding curve for a allergen:ligand complex formation with a Kd of 491 
See notes added to 
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0.4µM and and an apparent stoichiometry consistent with one binding site per protein 492 
monomer unit. 493 
 494 
Figure 4. Structural model of Der p 13 495 
Panel A: model of the apo form of Der p 13 based on the NMR structure of Der f 13 (PDB 496 
code 2A0A). Residue 57 is in yellow. Panel B: model of Der p 13 structure based on the X-497 
ray structure of myelin P2 protein from equine spinal cord (PDB code 1YIV). Residue 57 is 498 
in light pink. Panel C: surface representation of the structure of the complex between the 499 
model of the Der p 13 holo form (in purple) and cPNA (in red sticks), obtained by docking 500 
simulations.  501 
 502 
Figure 5. rDer p 13 activates airway epithelial cells through TLR2 signaling pathway 503 
Stimulation of BEAS-2B cells by rDer p 13 triggers IL-8 (Panel A) and GM-CSF (Panel B) 504 
cytokine production in a concentration dependent manner. BMMY medium from cultured 505 
wild-type P.pastoris and purified according to the purification protocol of rDer p 13 (WT 506 
KM71) as well as Pam3Cys were used as negative and positive controls respectively. To 507 
assess the importance of TLR2 signaling in the rDer p 13-induced activation, cells were also 508 
preincubated with blocking anti-TLR2 antibody or isotype control (Panel C) prior to allergen 509 
treatment. In another set of experiments,cells were transfected with dominant negative 510 
MyD88 or control plasmid followed by the rDer p 13 stimulation (Panel D). BEAS-2B cells 511 
were preincubated with SP600125, SB203580, U0126 (MAPK pathway inhibitors) or 512 
MG132, BAY 11-7082 (NF-º B pathway inhibitors) before treatment with rDer p 13 (Panel 513 
E). rDer p 13 was extensively digested with Trypsin at 37C (Panel F, lane 3). As control, 514 
undigested rDer p 13 (lane 1) was also preincubated at 37C (lane 2). Prior to cell activation 515 
by the different rDer p 13 forms (Panel G), trypsin was removed using immobilized 516 
benzamidine matrix. To control the removal of trypsin, cells were also activated with trypsin 517 
alone which was previously applied onto the same benzamidine beads. Data show mean 518 
cytokine concentrations + SEM and are representative of three independent experiments. ** 519 
P< 0.05, *** P<0.001.  520 
521 
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